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RESEARCH ARTICLE
Prescription of antibiotics for urinary tract infection in general
practice in Denmark
Anne Holm, Gloria Cordoba and Rune Aabenhus
Research Unit for General practice and Department of General Practice, University of Copenhagen, Copenhagen, Denmark
ABSTRACT
Objective: The aim of this study was to describe and characterize the prescription of antibiotics
for urinary tract infection (UTI) in general practice in Denmark and to evaluate compliance with
current recommendations.
Design: National registry-based study
Setting: Danish general practice
Patients: 267.539 patients who redeemed a prescription for antibiotics with the clinical indica-
tion UTI at community pharmacies between July 1st 2012 and June 31st 2013.
Main outcome measures: Antibiotics prescribed for 1) acute lower UTI, 2) acute upper UTI and
3) recurrent UTI presented as amount of prescriptions, number of treatments per 1000 inhabi-
tants per day (TID) and defined daily doses per 1000 inhabitants per day (DID).
Results: A total of 507.532 prescriptions were issued to 267.539 patients during the one year
study period, representing 2.35 DID. Acute lower UTI was the most common reason for prescrip-
tion of antibiotics (89.5%) followed by recurrent UTI (8.4%). The majority of the prescriptions
were issued to people above 60 year old (57.6%). Pivmecillinam was the most commonly pre-
scribed antibiotic in acute lower (45.8%) and acute upper (63.3%) UTI. Trimethroprim was the
most commonly prescribed antibiotic in recurrent UTI (45.9%). Prescription of quinolones
increased with increasing patient-age (p¼<.0001).
Conclusion: Compliance with current Danish recommendations was moderately high.
Pivmecillinam is the first line antibiotic for the management of acute lower and upper UTI, and
trimethroprim is the first line option of recurrent UTI. A high proportion of the antibiotic pre-
scriptions were issued in the elderly population including a relatively high prescription rate
of quinolones.
KEY POINTS
 Urinary tract infection (UTI) is a common cause for prescription of antibiotics in gen-
eral practice
 Poor compliance in general practice with recommendations for first-line treatment of UTI
may increase antibiotic resistance
 Danish general practitioners are generally compliant with national and regional guidelines for
antibiotic treatment of UTI
 There is high use of antibiotics in the elderly population including a worrisome high use of
broad-spectrum antibiotics, such as Quinolones.
ARTICLE HISTORY
Received 22 June 2018
Accepted 25 November 2018
KEYWORDS
Urinary tract infections;
antibiotics; general practice
Introduction
Urinary tract infection (UTI) is a common condition in
primary care and the associated costs are significant
to the patient as well as society [1,2]. UTI is a leading
cause for antibiotic prescribing in general practice,
second only to respiratory tract infections [3].
Antibiotics for UTI have been shown to shorten the
duration of symptoms and prevent recurrent infections
[4,5], but difficulties in correctly identifying bacterial
UTIs where antibiotics are beneficial from self-limiting
UTIs, suggests that a high level of overtreatment is
likely [6]. Excessive and inappropriate antibiotic pre-
scribing only serves to increase unwanted side effects
and the risk of antibiotic resistance both in individu-
ally treated patients and at the societal level [7,8].
In order to improve the use of antibiotics, the pre-
scription of antibiotics for specific conditions must be
continuously monitored to effectively implement
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antimicrobial stewardship programmes. Such antibiotic
surveillance systems can provide important sources of
information for healthcare professionals and policy
makers monitoring progress towards a more prudent
use of antibiotics, in turn ensuring adequate patient
treatment, and limiting spread of antibiotic resist-
ance [3,9].
In Denmark, no official national guideline regarding
treatment of UTI exists. Doctors are expected to stay
updated with regional guidelines and with national
recommendations from The Institute for Rational
Pharmacotherapy (IRF), a unit under the Danish
National Board of Health. The available recommenda-
tion from three regions and from IRF can be seen in
Table 1 [10–13]. Before 2016, nitrofurantoine was also
recommended as a first-line antibiotic for prevention
of UTI in some regions, but this drug was removed
from guidelines after a warning from the Danish
Health Authorities based on reports of pulmonary
fibrosis following long-term use. In 2013, resistance in
E. Coli isolates from primary health care was 6% for
mecillinam, 40% for ampicillin and 33% for sulfona-
mide [14].
The aim of this study was to describe and charac-
terize the prescription of antibiotics for urinary tract
infections treated in general practice in Denmark
between1st July 2012 to 31st June 2013, and to evalu-
ate the accordance of issued antibiotic prescriptions
with current national and regional guidelines.
Material and methods
Data sources
In Denmark, antibiotics are only available by prescrip-
tion, and dispensing in the primary care sector is
exclusively managed by community pharmacies. We
created a database including all Danish citizens who
redeemed an antibiotic prescription (ATC J01, see
below for details) at a community pharmacy between
July 1st 2012 to June 31st 2013 [15].
National data on prescription of antibiotic therapy
in Denmark was extracted from the Danish National
Prescription Database33. This registry contains com-
plete information on all prescriptions redeemed by
Danish residents at community pharmacies. For each
redeemed prescription, the registry contains informa-
tion on the following variables relevant to this study:
provider practice identification number (encrypted),
personal security number for each patient (encrypted),
type of antibiotic, age, gender and clinical indication.
In primary care, a clinical indication must be
entered when prescribing an antibiotic in the elec-
tronic prescription system. An option to use the
unspecific indication “Infection” is available for all anti-
biotic types and lastly the general practitioner (GP)
may choose to enter a free text indication. Presently
these free text indications are automatically coded as
“missing” in the electronic prescription system. The
available clinical indications are not formally validated
such as International Classification of Primary Care
(ICPC)-2 codes [16]. We have previously described use
of these clinical indications for assessing antibiotic use
and congruence with guidelines on antibiotic use in
respiratory tract infections general practice [3].
Antibiotic agents were classified according to the
Anatomical Therapeutic Chemical (ATC) index (J01
antibacterial agents for systemic use), down to 5th
level; chemical substance34.
General practice providers were identified by the
unique identifiers for general practitioners (GPs)
(encrypted), obtained from Statens Serum Institute, to
distinguish GP prescriptions from the entire primary
Table 1. Danish recommendations from three different regions and the national Institute for Rational Pharmacotherapy for treat-
ment of acute UTI and prevention of recurrent UTI.
Institute for Rational
Pharmacotherapy, 2009 [10] Capital Region, 2016 [11] Northern Region, 2011 [12] Region Sealand, 2016 [13]
Uncomplicated, lower UTI Pivmecillinam
sulfametizole or
trimethtroprim
No recommendation on
dose or duration
Pivmecillinam 400mg  3,
sulfametizole 1 g  2 or
trimethtroprim 200mg  2
3 days duration
Sulfametizole 1 g  2
3 days duration
Pivmecillinam 400mg  3,
sulfametizole 1 g  2
3 days duration
Complicated, lower UTI Pivmecillinam
No recommendation on
dose or duration
Pivmecillinam 400mg  3, or
trimethtroprim 200mg  2
5 days duration
Pivmecillinam 400mg  3
6 days duration
Pivmecillinam 400mg  3
6 days duration
Pyelonephritis Pivmecillinam
No recommendation on
dose or duration
Pivmecillinam
400mg  3
14 days duration
Pivmecillinam 400mg  3
14 days duration
Pivmecillinam 400mg  3
14 days duration
Prevention of recurrent UTI No recommendation Pivmecillinam 200mg  1 or
Trimethtroprim 100mg  1
No recommendation Trimethroprim 100mg  1 or
nitrofurantoine 50mg  1
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care sector32. All information on patient and prescriber
level was encrypted, and to protect against secondary
identification, all variables with cell counts less than 6
patients were grouped as “few”.
Statistikbanken.dk, a service from the Statistics
Danmark, was used to determine population size
in total.
Analyses
A dataset consisting of clinical indications and anti-
biotic prescriptions, issued exclusively by GPs, was cre-
ated by merging datasets by the unique practice
identification numbers [15].
The clinical indications for UTI were grouped and
analyzed as acute lower UTI, acute upper UTI and
recurrent UTI (including preventive treatment for UTI).
Descriptive analyses of prescription of antibiotics were
performed such as percentages, cumulated percen-
tages and number of treatments (TID) per 1000 inhabi-
tants per day and Defined Daily Doses (DDD) per 1000
inhabitants per day (DID). DID was calculated as fol-
lows: DDD1000/number of inhabitants (2012)/365.
There were 5,580,516 inhabitants by 31st
December, 2012.
Association between age group and type of anti-
biotic was assessed with the Chi-Square statistic test.
In addition, compliance with current recommenda-
tions was assessed by comparing regional and
national guidelines as illustrated in Table 1.
Recommendations for treatment of UTI have only
changed since 2013 in terms of not recommending
nitrofurantoine as first-line treatment for prevention
of UTI.
All calculations were done in SAS version 9.3 (Cary,
NC, USA).
Results
A total of 507.532 prescriptions (2.35 DID) were issued
in general practice to 267.539 patients with the indica-
tion UTI from 1st of July 2012 to 31st of June 2013.
Women accounted for the majority of the prescrip-
tions (81.7% of the prescriptions/77.6% of total DID).
Elderly patients were more exposed to antibiotics with
57.6% of the prescriptions (64.5% of total DID) issued
to people above 60 years of age, and this exposure
increased with more advanced age. Acute lower UTI
was the most common indication for prescribing anti-
biotics (89.5% of prescriptions/80% of total DID).
Upper UTI e.g. pyelonephritis was a relatively uncom-
mon clinical indication (2.1% of prescriptions/0.4% of
total DID). Recurrent UTI accounted for 8.4% of pre-
scriptions but 19.6% of DID. See Table 2 for details.
Pivmecillinam was the most common antibiotic pre-
scribed for acute lower (45.8% of the prescriptions)
and upper (63.4% of the prescriptions) UTI.
Sulfonamide was the second most common choice in
patients with acute lower UTI (27% of the prescrip-
tions), while quinolones were the second most com-
mon choice for acute upper UTI (19.7% of the
prescriptions). The two most common antibiotics pre-
scribed for recurrent UTI were trimethroprim (45.9% of
the prescriptions) and nitrofurantoin (28.8% of the pre-
scriptions) (Figure 1).
Pivmecillinam and sulfonamide were the most com-
monly prescribed antibiotics in all age groups (Figure
2). The prescription of quinolones increased with
increasing patient age (p¼<.0001).
The clinical indication “recurrent UTI” was respon-
sible for a larger percentage 19.6% of total DID. The
majority of DID (86%) were prescribed for patients
who were 60 years or older. nitrofurantoine and tri-
methroprim accounted for the majority of DID in all
age groups, but methenamin was also commonly pre-
scribed for recurrent UTI (Figure 3).
Discussion
Principal findings
This study on 507.532 prescriptions issued to patients
with the clinical indication UTI in general practice
showed that the most commonly prescribed antibiot-
ics for acute lower UTI were sulfamethizole and pivme-
cillinam. Pivmeciilinam was also the most commonly
prescribed antibiotic for acute upper UTI, while for
recurrent UTI, nitrofurantoine and trimethroprim were
the preferred choice of antibiotics. This was in
Table 2. Distribution of demographic factors and indication
in patients with Urinary tract infection prescribed antibiotics
in general practice- Denmark.
Number of
prescriptions (%) DID (%) TID (%)
Total 507.532 (100.0) 2.35 (100.0) 0.24 (100.0)
Women 414.942 (81.7) 1.82 (77.6) 0.20 (81.7)
Age
0–14 14.522 (2.8) 0.04 (1.8) 0.0007 (2.8)
15–29 66.296 (13.0) 0.23 (9.9) 0.032 (13.0)
30–44 59.415 (11.7) 0.23 (9.9) 0.029 (11.7)
45–59 74.402 (14.6) 0.32 (13.8) 0.036 (14.6)
60–69 119.890 (23.6) 0.60 (25.8) 0.058 (23.6)
þ75 173.007 (34.0) 0.91 (38.7) 0.084 (34.0)
Indication
Acute lower (UTI) 454.411 (89.5) 1.88 (80.0) 0.22 (89.5)
Acute upper (UTI) 1.108 (2.1) 0.006 (0.4) 0.0005 (2.1)
Recurrent lower (UTI) 52.013 (8.4) 0.46 (19.6) 0.025 (8.4)
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accordance with Regional and National guidelines.
However, the prescription of quinolones increased
with increasing age. Methenamin was commonly used
for chronic UTI, although not included in the guide-
lines. Acute UTI accounted for the majority of issued
prescriptions but prevention of recurrent UTI
accounted for a substantial amount of DID.
Strengths and weaknesses
Using a national registry-based cohort involving all
prescriptions with the clinical indication UTI was an
appropriate design to characterize UTI prescriptions.
The data are quite likely to reflect the actual use as all
data was routinely collected by electronic data capture
from all GPs in Denmark. Furthermore, the amount of
non-prescribed antibiotic use was negligible as
antibiotics are prescription-only drugs an all redeemed
prescriptions are included in the data.
Of note, it was not mandatory at the time the data
for this study was obtained, to assign a precise indica-
tion when issuing an antibiotic prescription [5]. First-
line antibiotics used for UTI in Denmark are, however,
not used on other indications. Pivmecillinam and sulfa-
methizole prescriptions contained an indication in
84% of prescriptions and the indication was UTI in
98% of these cases, which makes our data quite valid.
The number of missing indications in the national pre-
scription data was rather high (32%) [3]. Still, in com-
parison to other clinical indications such as respiratory
tract infections [17] the prescribing of a urinary tract
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Figure 1. Cumulative percentages of prescriptions by antibiotic type and indications in patients with suspected urinary tract infec-
tion prescribed antibiotics in general practice- Denmark.
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Figure 2. Cumulative percentages of prescriptions by anti-
biotic type and by age group in patients with suspected
urinary tract infection prescribed antibiotics in general
practice- Denmark.
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agent (trimethoprim, nitrofurantoin, mecillinam or sul-
phamide) halved the risk of a missing indication on an
electronic prescription (OR 0.50, 95% CI 0.48–0.52) [3].
However, there might be ciprofloxacin or amoxicillin
prescriptions in the database with other indications or
lacking an indication that were actually used for UTI.
Thus, underreporting of these drugs for UTI is pos-
sible. This study might also underestimate inappropri-
ate treatment especially in the elderly where a precise
diagnosis can be difficult to establish [18]. Dividing
the indications into acute UTI and prevention of recur-
rent UTI may not be completely solid either and sys-
tematic differences in labelling the clinical indications
acute/recurrent UTI may occur. However, it is difficult
to estimate the direction of such a bias.
Another weakness of our study is the lack of an
officially recognized guideline for treatment of UTI in
general practice. Nonetheless, the available guidelines
were in relatively good accordance since all of them
recommended using pivmecillinam in most cases of
acute UTI. However, sulfamethizole remained the drug
of choice in the Northern region of Denmark.
Recommendations for prevention of acute UTI were
not completely consistent either. The two guidelines
that mentioned this indication both recommended tri-
methroprim, but one still recommended nitrofuran-
toine as the alternative choice and the other
recommended pivmecillinam. Also, we were unable to
determine if antibiotics treatment was appropriate
due to the lack of clinical data in the database.
Methenamine was used quite extensively for preven-
tion of UTI in the elderly despite no guidelines men-
tioning this drug. Little research exists on the use of
methenamine for prevention of UTI, but a Cochrane
review has shown promising results [19]. The use of
nitrofurantoine for treatment of acute UTI was also
higher than what would be expected from guideline
recommendations. This may be appropriate since
nitrofurantoine has low resistence rates even in coun-
tries with higher use [20].
Relation to the literature
Kobayashi et al performed a database study on out-
patient visits regarding UTI from 2002 to 2011 and
found that out of 7111 visits, about 80% were treated
with antibiotics and almost half of this use was flouro-
quinolones [21]. The second-most commonly pre-
scribed antibiotics were sulfonamides and
nitrofurantoine despite the recommended first-line
choice was sulfamethizole-trimethroprim. In line with
our findings, they found older patients more likely to
receive flouroquinolone treatment than younger
patients. They concluded that the use of broad-spec-
trum treatment for elderly patients could be driven
partly by resistance towards first-line antibiotics and
partly by possible impaired renal function in the eld-
erly, limiting the use of nitrofurantoine, although it is
now only recommended to avoid long-term use in
patients with loss of renal function [22]. A Norwegian
study, however, found that elderly people in nursing
homes were not at an increased risk of having resist-
ant infection compared to home-living elderly [23].,
Denmark is one of the only countries in the world rec-
ommending sulfamethizole as a first-line antibiotic for
uncomplicated UTI. This may be due to a Danish study
showing sulfamethizole to be clinically as effective as
pivmecillinam despite high resistance-rates [24].
The other Nordic countries have different recom-
mendations for prescription of antibiotics for UTI. This
may affect both total consumption of antibiotics and
resistance rates [25].
The prescription of antibiotics to the elderly popu-
lation in our study was relatively high. Furthermore, a
higher level of second-line agents were used in this
patient group. We do not have sufficient clinical data
to assess if this antibiotic pattern of use was appropri-
ate, but it is an area that should call for concern. We
find it unlikely that the observed steep increase in
antibiotic use for UTI with increasing age reflects a
correspondingly steep increase in the incidence of UTI
with age. Broad-spectrum agents were more often
used in the elderly population as well. This may reflect
treatment-failure or antibiotic resistance, but it could
also be caused by the difficulty in determining the site
of infection in an elderly deranged patient, causing
doctors to prescribe more broad-spectrum to cover a
possible respiratory focus as well [26,27]. Also, the
ease of administrating quinolones may be contribute.
A Dutch study from 2015 found that antibiotic over-
treatment in nursing homes was a larger problem
than antibiotic undertreatment [28]. The increasing
prevalence of asymptomatic bacteriuria with increas-
ing age is also a likely cause for a higher use of antibi-
otics for suspected UTI [29].
Meaning of the study and implications
for practice
Danish GPs were generally compliant with national
and regional guidelines when prescribing antibiotics
for patients with suspected UTI. However, increasing
use of broad-spectrum agents with increasing age
including a relatively high prescription rate of
SCANDINAVIAN JOURNAL OF PRIMARY HEALTH CARE 5
quinolones should cause concern. Also, extensive use
of antibiotics for prevention of UTI in the elderly
population could introduce high resistance-rates in
nursing-homes and antibiotic-related adverse out-
comes in the elderly population [30]. Future initiatives
to reduce inappropriate antibiotics for patients with
suspected UTI should focus on promoting use of first-
line antibiotics and new initiatives to reduce use of
broad-spectrum agents and antibiotics for prevention
of UTI especially in the elderly population.
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